Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Complete rest from aggravating activities for at least the first 2 to 4 weeks of treatment allows the enhanced healing response to gain traction before gradually reintroducing load
Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Description FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction, supplied as a lyophilized 10mg vial
Though the recommended doses are not expected to cause adverse effects for the infant, there are no human studies available to assess the risks
Nerve health support
US$ 22.22
US$ 21.73
US$ 29.58
US$ 20.46
